This compound is an ester derivative of a benzimidazole, characterized by a methyl and a propyl substituent on the heterocyclic ring system. It is primarily used as a pharmaceutical intermediate in chemical synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
4-Methyl-2-n-propyl-1H-benzimidazole-6-carboxylic acid
pharmaceutical intermediate
Methyl 4-(butyrylamino)-3-methyl-5-nitrobenzoate
pharmaceutical intermediate
4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazole
pharmaceutical intermediate
5-Hydroxynicotinonitrile
pharmaceutical intermediate
(2S,3R,4S,5S)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,6-bis(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
pharmaceutical intermediate
methyl 7-methyl-2-propyl-3H-benzimidazole-5-carboxylate
DEFDQXCQBZEOGY-UHFFFAOYSA-N
CCCC1=NC2=C(N1)C=C(C=C2C)C(=O)OC
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.